VEGF- and PlGF-targeting fusion protein inhibits tumor progression by activating antitumor immunity
Oct. 13, 2023
Researchers from Panolos Bioscience Inc. and affiliated organizations have published preclinical data for PB-101, a novel glycosylated decoy protein targeting both vascular endothelial growth factor (VEGF) and placental growth factor (PlGF).
